Clinical Trial

A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis

Name: A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis — clinical trial record (NCT07309055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This trial was designed to evaluate the efficacy and safety of SHR-1819 in adolescents with moderate-to-severe atopic dermatitis.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-08

Trial Details

NCT Number	NCT07309055
Lead Sponsor	Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions	Adolescents With Moderate-to-severe Atopic Dermatitis
Enrollment	201 participants
Start Date	2026-03-21
Primary Completion	2027-11 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-07